BEBTELOVIMAB
UNII 8YL4SYR6CU

Substance Identification & Data

This profile provides standardized clinical and technical data for Bebtelovimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8YL4SYR6CU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2578319-11-4 and the RxNorm Concept ID (RxCUI) 2592360. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8YL4SYR6CU

CAS Registry Number

2578319-11-4

RxNorm Concept ID

2592360

Detailed Substance Profile

Preferred Name

BEBTELOVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C182122

National Cancer Institute reference terminology for clinical and research data.

INN ID

12145

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-200

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bebtelovimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BEBTELOVIMAB

Common Names & Synonyms

BEBTELOVIMAB [INN]

BEBTELOVIMAB [USAN]

BEBTELOVIMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3853113 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3853113 .LAMBDA.-CHAIN, DIMER